Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can fewer dressing changes make PICC lines safer?

NCT ID NCT07802314

Disease control Sponsor: Fundacion Miguel Servet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial compares different care schedules for peripherally inserted central catheters (PICCs), which are long-term IV lines. Researchers want to see if extending the time between dressing changes, while using special securement and antiseptic dressings, reduces infections and other complications. The study includes 240 adults who need a PICC and can manage their own daily activities. Participants will be assigned to one of several care routines, and the team will track complications like phlebitis, bloodstream infections, and accidental line removal.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Different care frequencies for peripherally inserted central catheters (PICCs), including use of SecurAcath securement and chlorhexidine dressings
What this could lead to
If successful, this could establish safer, less frequent care routines for PICC lines, reducing infections and other complications while improving patient comfort.
What could go wrong
The trial is relatively small and focuses on a specific care protocol, so results may not apply to all hospitals or patient groups. Complications can still occur despite optimized care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 240 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * be over 18 years of age * accept participation in the study * independent patient in the care and management of activities of daily living Exclusion Criteria: * patient over 18 years of age * patient with functional or cognitive limitation * patient with mild, moderate or high level of dependence * patient does not accept to perform the study * patient with device withdrawal prior to 14 days of duration

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NURSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NURSE Treatment (proudme) Vascular access Vascular access complication

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.